MedTrace Logo

External Validation of VAN, VES and LARIO Scales in Suspected Acute Stroke

NCT06024330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 614

Last updated 2024-08-14

No results posted yet for this study

Summary

In acute ischemic stroke, treatments include intravenous thrombolysis (IVT) and mechanical thrombectomy (MT). IVT is viable up to 4.5 hours post-stroke onset, while MT is applicable within 24 hours but primarily for large vessel occlusions. MT is specialized and performed in select stroke centers. Effective early triage improves neurological outcomes. Pre-hospital stroke severity assessment and direct transfers for MT are crucial. Although the National Institute of Health Stroke Scale (NIHSS) is widely recognized, its practicality is limited in emergency settings due to its complexity. Alternative scoring systems like LAMS, CPSS, and RACE have been introduced but have limitations. Recently developed scores, namely Vision, Aphasia, and Neglect (VAN), Ventura Emergency Large Vessel Occlusion (VES), and Large Artery Intracranial Occlusion Stroke Scale (LARIO), demonstrate promising diagnostic accuracy in pilot studies, suggesting potential benefits for early detection, appropriate triage, and better neurological outcomes

Conditions

Interventions

DIAGNOSTIC_TEST

VAN assessment

An investigator assesses the VAN scale when a patient arrives at ED triage with a suspected stroke.

DIAGNOSTIC_TEST

VES assessment

An investigator assesses the VES scale when a patient arrives at ED triage with a suspected stroke.

DIAGNOSTIC_TEST

LARIO assessment

An investigator assesses the LARIO scale when a patient arrives at ED triage with a suspected stroke.

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-10-01
Completion
2023-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06024330 on ClinicalTrials.gov